Lazard Asset Management
ZYME icon

Lazard Asset Management’s Zymeworks ZYME Stock Holding History

Lazard Asset Management’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$265K Sell
10,602
-3,174
-23% -$75.1K ﹤0.01% 1545
2025
Q4 		$363K Sell
13,776
-1,532
-10% -$33.4K ﹤0.01% 1474
2025
Q3 		$261K Buy
+15,308
New +$219K ﹤0.01% 1528
2025
Q2 		– Sell
-3,787
Closed -$45K – 2564
2025
Q1 		$45K Buy
+3,787
New +$51.6K ﹤0.01% 2019
2024
Q4 		– Sell
-9,561
Closed -$119K – 2576
2024
Q3 		$119K Buy
+9,561
New +$104K ﹤0.01% 1744
2024
Q2 		– Sell
-6,057
Closed -$63K – 2454
2024
Q1 		$63K Sell
6,057
-22,014
-78% -$244K ﹤0.01% 1675
2023
Q4 		$290K Buy
28,071
+12,242
+77% +$97.6K ﹤0.01% 1272
2023
Q3 		$99K Sell
15,829
-16,154
-51% -$119K ﹤0.01% 1638
2023
Q2 		$275K Buy
31,983
+9,335
+41% +$83.6K ﹤0.01% 1252
2023
Q1 		$204K Buy
22,648
+5,020
+28% +$43.8K ﹤0.01% 1309
2022
Q4 		$138K Hold
17,628
– – ﹤0.01% 1402
2022
Q3 		$108K Hold
17,628
– – ﹤0.01% 1441
2022
Q2 		$93K Buy
17,628
+7,511
+74% +$45.4K ﹤0.01% 1534
2022
Q1 		$66K Buy
+10,117
New +$90.2K ﹤0.01% 1607

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Lazard Asset Management's ZYME Position: Q1 2026 in Review

Lazard Asset Management reduced its Zymeworks (ZYME) stake by 23% in Q1 2026, selling an estimated $75.1K and leaving 10,602 shares worth $265K. The position accounts for ﹤0.01% of the portfolio, ranked #1545.

Lazard Asset Management first reported a position in ZYME in Q1 2022 and has held it in 14 quarters since. The position peaked at $363K in Q4 2025. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Lazard Asset Management held 10,602 shares of Zymeworks worth $265K as of Q1 2026.
  • Lazard Asset Management sold 3,174 Zymeworks shares in Q1 2026, an estimated $75.1K.
  • Zymeworks made up ﹤0.01% of Lazard Asset Management's portfolio in Q1 2026, its #1545 holding.
  • Lazard Asset Management first reported a position in Zymeworks in Q1 2022 and has held it in 14 quarters since.
  • Lazard Asset Management's Zymeworks position peaked at $363K in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Lazard Asset Management's 13F filing for Q1 2026, filed 15 May 2026.